7-Methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline(CAS: 1002304-34-8)

7-Methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline (CAS: 1002304-34-8) is subject to various regulatory guidelines including the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. Specific guidelines may include proper labeling, storage, disposal, and safety data sheets (SDS).

7-Methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline (CAS: 1002304-34-8) may be synthesized using alternatives such as 7-methoxyquinoline and various hydrazine derivatives. These alternatives can offer similar chemical functionalities but may differ in reactivity and synthesis conditions.

The market trend for 7-Methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline (CAS: 1002304-34-8) is driven by its potential applications in pharmaceuticals and materials science. Research trends include its use as a precursor in drug development and as a component in advanced materials. Market demand is expected to grow due to increasing pharmaceutical research and development activities.

Waste containing 7-Methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline (CAS: 1002304-34-8) should be collected in appropriate containers, labeled for chemical waste, and disposed of through professional waste disposal services. Incineration or other controlled disposal methods should be employed to minimize environmental impact. Compliance with local environmental regulations is essential.